financetom
Business
financetom
/
Business
/
Aurora Innovation Insider Sold Shares Worth $27,455,944, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Aurora Innovation Insider Sold Shares Worth $27,455,944, According to a Recent SEC Filing
Nov 9, 2024 1:35 PM

05:25 PM EST, 11/08/2024 (MT Newswires) -- Reid Hoffman, Director, on November 06, 2024, sold 4,929,713 shares in Aurora Innovation ( AUR ) for $27,455,944. Following the Form 4 filing with the SEC, Hoffman has control over a total of 9,154,991 shares of the company, with 286,247 shares held directly and 8,868,744 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1828108/000182810824000145/xslF345X05/wk-form4_1731103992.xml

Price: 5.19, Change: +0.01, Percent Change: +0.19

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3
Form 8.3
Jun 17, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: River Global Investors LLP - 213800HIGHFCAY9K8Z97 (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming...
Vedana Therapeutics launches with $46 million to develop migraine treatments
Vedana Therapeutics launches with $46 million to develop migraine treatments
Jun 17, 2026
June 17 (Reuters) - Vedana Therapeutics emerged from stealth on Wednesday with $46 million in funding, which will be used to develop next-generation therapies for migraine prevention. Here are the details: * The Series A financing round was co-led by Westlake BioPartners and Canaan Partners, with participation from Dawn Biopharma and Alexandria Venture Investments. * Migraine, which affects more than...
Knot Offshore Partners Insider Bought Shares Worth $25,000,000, According to a Recent SEC Filing
Knot Offshore Partners Insider Bought Shares Worth $25,000,000, According to a Recent SEC Filing
Jun 17, 2026
04:11 AM EDT, 06/17/2026 (MT Newswires) -- Trygve Seglem, Director, on June 15, 2026, executed a purchase for 1,250,000 shares in Knot Offshore Partners ( KNOP ) for $25,000,000. Following the Form 4 filing with the SEC, Seglem has control over a total of 11,462,361 shares of the company, with 1,458,333 Series A preferred units, 9,661,255 common units, 90,368 common...
Aegon Names Will Fuller as Chief Operating Officer
Aegon Names Will Fuller as Chief Operating Officer
Jun 17, 2026
04:15 AM EDT, 06/17/2026 (MT Newswires) -- Aegon ( AEG ) has appointed Will Fuller as chief operating officer, effective Jan. 1, 2027, the company said Wednesday. Fuller currently serves as chief executive of Aegon's ( AEG ) Transamerica operations. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved